Syringe and Needle Market by End-user and Geography - Forecast and Analysis 2022-2026

“The Syringe and Needle Market  study is a comprehensive report with in-depth qualitative and quantitative research evaluating the current scenario and analyzing the growth USD 7.83 billion and CAGR of 7.42% by segment End-user & Geography during the forecast period 2022 to 2027” 

Furthermore, this report extensively covers the smart home appliances market segmentation by end-user (Hospitals and clinics, Home care, Other) and geography (North America, Europe, APAC, South America, and MEA). The market report also offers information on several market vendors, including. Braun Melsungen AG, Becton Dickinson and Co., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Hindustan Syringes and Medical Devices Ltd., Nipro Corp., SCHOTT AG, Smiths Group Plc, and Terumo Corp.

Download Report Sample to Unlock the Smart Room Heater Market Size for the Forecast Period and Other Important Statistics 

Parent Market Analysis

Technavio categorizes the Syringe and Needle Market as a part of the Health care industry within the Health Care Equipment and Supplies industry. Our Technavio research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the forecast year.

Syringe And Needle Market: Key Drivers, Trends, and Challenges

Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the smart room heater industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge. 

Key Syringe And Needle Market Driver

The increasing prevalence of critical care conditions is one of the key drivers supporting the syringe and market share growth. Gallbladder cancer is uncommon in developing countries such as India and China but is a highly fatal malignancy. It includes cholelithiasis, congenital biliary abnormalities, and others. Syringes and needles are used for the identification of non-biliary blocks as well. These stents are also used to treat peripheral vascular diseases due to their cost-effectiveness. Moreover, due to the increase in the number of pancreatic cancer, bile duct diseases, and gallbladder-related diseases, vendors are focusing on developing new and innovative products from time to time to penetrate the market that helps in the growth of the market. Such factors will propel the growth of the syringe and needle market during the forecast period.

Key Syringe And Needle Market Challenge

Competition from alternative drug delivery systems may be hinder the syringe and needle market share growth in the coming years. The global syringe and needle market faces intense competition from alternative drug delivery systems such as microneedles, wearable and connected delivery devices, and nanopatches. These drug delivery devices are non-invasive, are easier to use, provide painless delivery, and ensure the controlled release of the drug. Companies such as Unilife and Becton, Dickinson, and others have already introduced wearable injector devices in the market. These devices are used as an alternative to hand-held instruments such as syringes and needles, particularly when delivering a dosage over pre-programmed periods from minutes to hours. These alternatives will hinder the market growth during the forecast period.

Syringe And Needle Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the syringe and needle market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Who are the Major Syringe And Needle Market Vendors?

B. Braun Melsungen AG - The company offers syringe needle under the brand name of Sterican. The B. Braun Hospital Care segment offers products and services for patients, especially for infusion therapy, nutrition therapy, and pain therapy. Its products include infusion and nutrition solutions, as well as specific medications. The Aesculap division offers expertise in surgical, orthopedic, and interventional treatment concepts related to inpatient and outpatient care.

The report  on Syringe and Needle Market analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

• B. Braun Melsungen AG
• Becton Dickinson and Co.
• Cardinal Health Inc.
• CODAN Medizinische Gerate GmbH and Co KG
• Gerresheimer AG
• Hindustan Syringes and Medical Devices Ltd.
• Nipro Corp.
• SCHOTT AG
• Smiths Group Plc
• Terumo Corp.

 

This statistical study of the syringe and needle market encompasses successful business strategies deployed by the key vendors. The syringe and needle market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. The report syringe and needle market contains a comprehensive market knowledge and in-depth vendor landscape add on to an analysis of the key vendors.

Which are the Key Regions for Syringe And Needle Market?

For more insights on the market share of various regions Request PDF Sample now!

34% of the market’s growth will originate from North America during the forecast period. The US is the key market for syringes and needles in North America. Market growth in this region will be faster than the growth of the market in the European regions.

North America is the largest market for global syringes and needles, with the US being the major revenue contributor. The increasing prevalence of chronic diseases, such as diabetes and vaccine-preventable infectious diseases, is driving the growth of the market in this region. According to The World Bank Group, about 10.46% of the total population was living with diabetes in North America in 2019. With the increasing prevalence of chronic diseases, the demand for syringes and needles is expected to increase during the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 has led to an increase in the demand for syringes and needles owing to the production and distribution of vaccinations in North America. For example, the US government has invested in a deal worth USD138 million with the producers of syringes to empower and manufacture 100 million syringes and needles to be used for the COVID-19 vaccination by the end of the year 2020 and over 500 million for the year 2021. This will increase the demand for syringes and needles in the region during the forecast period.

What are the Revenue-generating End-user Segments in the Syringe And Needle Market?

To gain further insights on the market contribution of various segments Request a PDF Sample

The syringe and needle market share growth by the hospitals and clinics segment will be significant during the forecast period. Hospitals and clinics account for a major share in the global syringe and needle market. Syringes and needles are most commonly used in hospitals for administering vaccines, anticoagulants, other biologics, and drugs. There is an increased demand for syringe and needle drug delivery from healthcare professionals, owing to its benefits such as ease of administration, accurate dosing, and increased storage time. The majority of healthcare professionals prefer to use syringes and needles instead of conventional needles and syringes for drug delivery. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the syringe and needle market size and actionable market insights on post-COVID-19 impact on each segment.

Syringe and Needle Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 7.42%
Market growth 2022-2026	USD 7.83 billion
Market structure	Fragmented
YoY growth (%)	6.56
Regional analysis	North America, Europe, APAC, South America, and MEA
Performing market contribution	North America at 34%
Key consumer countries	US, Germany, France, China, and India
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	B. Braun Melsungen AG, Becton Dickinson and Co., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Gerresheimer AG, Hindustan Syringes and Medical Devices Ltd., Nipro Corp., SCHOTT AG, Smiths Group Plc, and Terumo Corp.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Syringe And Needle Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive syringe and needle market growth during the next five years
• Precise estimation of the syringe and needle market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the syringe and needle industry across North America, Europe, APAC, South America, and MEA
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of syringe and needle market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch